Regeneron Pharmaceuticals, Inc.
Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.
We’re in it for good. For the people who need more treatment options and for the breakthroughs that can change what’s possible in medicine.
It’s the reason we come to work every day, relentlessly searching for answers. We are in it for the future, pushing the bounds of science to shape the next frontier in medicine. We are in it for the families waiting on answers, for the communities who fuel our purpose.
Discover how we are advancing our mission to bring science to medicine: In It for Good
-
We had an entirely new marketing team, with the longest-tenured member having six years of experience. We found ourselves faced with an FDA approval after 3.5 months of review. It was the most challenging task I have ever encountered. We were building the plane while it was flying — while sourcing parts and reading the blueprints on how to put it together. Yet we were able to successfully launch with incredible results that exceeded all expectations.
John Bae, Associate Director of Marketing, Commercial -
We have an optimistic and highly collaborative approach to solving problems. When we experience failures — and there are a lot of them! — we don’t get down. We say, “Let’s go back and think about what we can change.” And we have multiple approaches going simultaneously, which is very Regeneron. We don’t limit ourselves to one way of doing things.
Lynn Macdonald, Vice President, Neuroscience, VI NEXT®, MPDS, BiCS, DNA Core & Automation
